SPRINT
First North Stockholm
Biotechnology & Pharmaceuticals
Health Care
Sprint Bioscience is a research company. The company develops drug candidates that can fight cancer individually or in combination with other drugs. The company has a portfolio of projects that are focused on attacking parts of the processes of cancer cells. The business model is based on a project portfolio and developing projects in parallel in the preclinical phase and then entering into licensing agreements with the global pharmaceutical industry. The company is headquartered in Huddinge.
Read moreRevenue M
EBIT-% (adj.)
EPS (adj.)
Dividend %
Interim report Q2'26
Interim report Q3'26
Annual report '26
Don't miss out - create an account and get all the possible benefits